Maternal and fetal outcome in pregnancy associated with malignancy: a case series at a tertiary care centre in India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252035Keywords:
Pregnancy, Malignancy, Germ cell tumour, Maternal and fetal outcome, ChemotherapyAbstract
Malignancy in pregnancy is rare presentation with an estimated incidence of 1 per 1000. Pregnancy with malignancy poses a unique challenge for treating physician because of the safety concerns for the unborn child. The aim of the study was describing the maternal and infant outcomes of malignancy in pregnancy and to describe the various treatment options according to tumour type and gestational age. A prospective observational study was done at tertiary care centre for 6 months from December 2020 to June 2021. A case series of pregnancy associated malignancy were observed and followed up till postpartum period. Three cases were of ovarian tumors with good maternal and fetal outcomes as they were in early stages of the disease. Fourth case was of metastatic lung carcinoma with adverse maternal outcome due to advanced malignancy. The conclusion was that a multidisciplinary approach of obstetrician, pathologist, radiologist, oncologist, onco-surgeon, neonatologist is necessary in managing these cases. The treatment strategy should be discussed and structured on an individual basis. A combined approach of surgery and chemotherapy is advocated depending on the stage of the disease and gestation. Neonatal outcomes like prematurity, low birth weight are anticipated and good overall maternal and fetal outcome can be achieved.
Metrics
References
Hepnera A, Negrinia D, Haseb E, Exmanc P, Testaa L, Angela F, et al. Cancer During Pregnancy: The Oncologist Overview. World J Oncol. 2019;10(1):28-34. DOI: https://doi.org/10.14740/wjon1177
Worldwide cancer data. World Cancer Research Fund. 2018. Available at: https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data. Accessed on 10th December 2019.
Coccia PF. Overview of adolescent and young adult oncology. J Oncol Pract. 2019;6:235-7. DOI: https://doi.org/10.1200/JOP.19.00075
Botha MH, Rajaram S, Karunaratne K. Cancer in pregnancy. Int J Gynecol Obstet. 2018;143(2):137-42. DOI: https://doi.org/10.1002/ijgo.12621
Korenaga T, Crosland B, Tewari K, Chapter 12. Cancers in pregnancy. DiSaia and Creasman Clinical Gynecologic OncologyBook, Tenth Edition; 2022. DOI: https://doi.org/10.1016/B978-0-323-77684-4.00021-0
Dow E, Freimund A, Smith K, Hicks RJ, Jurcevic P, Shackleton M, et al. Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model. JCO Precis Oncol. 2021;6:10-2. DOI: https://doi.org/10.1200/PO.20.00429
Baxter M, Denholm M, Kingdon S, Kathirgamakarthigeyan S, Parikh S, Shakir R et al. Cancer in Pregnancy (CARING)–a retrospective study of cancer diagnosed during pregnancy in the United Kingdom. British J Can. 2010;41:416-24.
Kumari M, Yenuberi H, Rathore S, Abraham D, Titus V.T.K., Mathews JE, et al. Pregnancy outcomes in non-gynecological and non-hematological cancers: a retrospective cohort. Int J Reprod Contracept Obstet Gynecol. 2020;9:1106-9. DOI: https://doi.org/10.18203/2320-1770.ijrcog20200883
Reddi RP, Vishalakshi AL. Cancer in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2018;7:2989-92. DOI: https://doi.org/10.18203/2320-1770.ijrcog20183288
Gezginc K, Karatayli R, Yazici F, Acar A, Celik C, Capar M. Ovarian cancer during pregnancy. Int J Gynaecol Obstet. 2011;115 (2):140–3. DOI: https://doi.org/10.1016/j.ijgo.2011.05.025
Aggarwal P, Kehoe S. Ovarian tumours in pregnancy: a literature review [J]. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):119–24. DOI: https://doi.org/10.1016/j.ejogrb.2010.11.023
Chen Y, Luo Y, Han C, Tian W, Yang W, Wang Y, et al. Ovarian dysgerminoma in pregnancy: A case report and literature review. Cancer Biol Ther. 2018;19(8):649-58. DOI: https://doi.org/10.1080/15384047.2018.1450118
Han SN, Lotgerink A, Gziri MM, Van Calsteren K, Hanssens, M, Amant F. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy:a systematic review. BMC Med. 2012;10:86. DOI: https://doi.org/10.1186/1741-7015-10-86
Pearl, J, Price R, Tonkin A, Richardson S, Stefanidis, D. SAGES guidelines for the use of laparoscopy during pregnancy. Surg Endosc. 2021;31:3767–82. DOI: https://doi.org/10.1007/s00464-017-5637-3
Morice P, Uzan C, Gouy S, Verschraegen C, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet. 2012;379(9815):558–69.
Schaefer C. Drug safety in pregnancy-a particular challenge. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(9):1129-38. DOI: https://doi.org/10.1007/s00103-018-2798-8
Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. Lancet. 2012;379(9815):570–9. DOI: https://doi.org/10.1016/S0140-6736(11)61092-1
Halaska MJ, Komar M, Vlk R. A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;174(1):76–9. DOI: https://doi.org/10.1016/j.ejogrb.2013.12.021
Morice P, Uzan C, Gouy S, Verschraegen C, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet. 2012;379(9815):558–69. DOI: https://doi.org/10.1016/S0140-6736(11)60829-5
Slimano F, Baudouin A, Zerbit J. Cancer, immune suppression and coronavirus disease-19 (COVID-19): need to manage drug safety (French society for oncology pharmacy guidelines) Cancer Treat Rev. 2020;88:102063. DOI: https://doi.org/10.1016/j.ctrv.2020.102063
Shah R, Xia C, Krailo M. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults. Gynecol Oncol. 2018;150(2):253–60. DOI: https://doi.org/10.1016/j.ygyno.2018.05.025
Downloads
Published
How to Cite
Issue
Section
